Top compounds associated with response to DOT1L


Feature Type Standardized
Nominal ANOVA
mRNA PX-12 CTRPv2 pan-cancer AAC 0.3 5e-17
mRNA barasertib CTRPv2 pan-cancer AAC 0.31 5e-15
mRNA indisulam CTRPv2 pan-cancer AAC 0.29 4e-13
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.31 7e-13
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.28 3e-12
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.26 3e-12
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.29 4e-12
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.29 4e-12
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.25 7e-12
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.27 2e-11
Download CSV